Variables | Number count | Percentage (%) |
Age (years) |
|
|
18 - 24 years | 10 | 20% |
25 - 34 years | 25 | 50% |
≥34 years | 15 | 30% |
Number of pregnancies |
|
|
1 | 10 | 20% |
2 - 3 | 14 | 28% |
³4 | 26 | 52% |
Matrimonial status |
|
|
Single | 20 | 40% |
In a relationship | 30 | 60% |
Preeclampsia risk factors |
|
|
Preeclampsia record in previous pregnancies | 2 | 4% |
Primiparity | 16 | 32% |
Twin pregnancy | 1 | 2% |
Diabetes | 1 | 2% |
Gestational age |
|
|
[24 - 28 WA[ | 2 | 4% |
[28 - 32 WA[ | 8 | 16% |
[32 - 37 WA[ | 16 | 32% |
[37 - 40 WA[ | 33 | 46% |
[40 - 44 WA[ | 1 | 2% |
HTA grade |
|
|
1 | 2 | 4% |
2 | 17 | 34% |
3 | 31 | 62% |
Albuminuria |
|
|
1 cross | 4 | 8% |
2 cross | 20 | 40% |
≥3 cross | 26 | 52% |
Biology |
|
|
Proteinuria/creatinuria ratio (mg/g) |
|
|
200 - 1000 | 9 | 18% |
1000 - 2000 | 18 | 30% |
2000 - 3000 | 7 | 14% |
3000 - 12000 | 16 | 32% |
Hypercreatininemia | 15 | 30% |
Anemia | 19 | 43.18% |
Thrompenia | 15 | 33% |
Elevated liver enzymes | 30 | 68.18% |
Low prothrombin | 2 | 6% |
AntiHTA treatment |
|
|
Calcium channel blockers | 44 | 88% |
Central antiHTA | 50 | 100% |
Alphablocker | 2 | 4% |
Fœtal extraction |
|
|
Vaginal delivery | 6 | 12% |
Cesarian-section | 44 | 88% |
Other treatment |
|
|
Corticoïds | 14 | 28% |
Loop diuretics | 2 | 4% |
Antibiotics | 44 | 88% |
Complications |
|
|
Maternal |
|
|
Eclampsia | 11 | 22% |
HELLP Sd | 08 | 16% |
RPH | 1 | 2% |
AKI | 15 | 30% |
Fœtal |
|
|
IUFD | 11 | 22% |
IUGR | 21 | 42% |
Prematurity | 26 | 52% |